Jump Financial LLC reduced its position in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 7.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,507 shares of the company’s stock after selling 2,429 shares during the period. Jump Financial LLC’s holdings in Colgate-Palmolive were worth $2,682,000 at the end of the most recent quarter.
Other hedge funds have also made changes to their positions in the company. Axxcess Wealth Management LLC boosted its stake in Colgate-Palmolive by 0.3% during the 4th quarter. Axxcess Wealth Management LLC now owns 38,786 shares of the company’s stock worth $3,526,000 after purchasing an additional 117 shares during the last quarter. Commonwealth Financial Services LLC lifted its stake in shares of Colgate-Palmolive by 4.5% in the fourth quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company’s stock worth $247,000 after buying an additional 118 shares in the last quarter. Wescott Financial Advisory Group LLC boosted its position in Colgate-Palmolive by 3.5% during the fourth quarter. Wescott Financial Advisory Group LLC now owns 3,517 shares of the company’s stock worth $320,000 after acquiring an additional 119 shares during the last quarter. D Orazio & Associates Inc. grew its stake in Colgate-Palmolive by 4.2% during the 4th quarter. D Orazio & Associates Inc. now owns 2,982 shares of the company’s stock valued at $271,000 after acquiring an additional 120 shares in the last quarter. Finally, Lantz Financial LLC grew its position in shares of Colgate-Palmolive by 0.6% in the fourth quarter. Lantz Financial LLC now owns 20,140 shares of the company’s stock valued at $1,831,000 after purchasing an additional 122 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.
Analysts Set New Price Targets
A number of analysts have issued reports on CL shares. UBS Group raised their target price on Colgate-Palmolive from $105.00 to $109.00 and gave the stock a “buy” rating in a research note on Thursday. Wells Fargo & Company boosted their target price on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the company an “underweight” rating in a report on Wednesday, April 2nd. Raymond James restated an “outperform” rating and set a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Stifel Nicolaus decreased their price objective on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a report on Monday, February 3rd. Finally, Piper Sandler cut their target price on Colgate-Palmolive from $108.00 to $107.00 and set an “overweight” rating for the company in a research note on Monday, March 31st. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $102.17.
Colgate-Palmolive Stock Up 2.1 %
Shares of NYSE:CL opened at $95.49 on Friday. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. The stock has a market cap of $77.45 billion, a P/E ratio of 27.13, a P/E/G ratio of 4.20 and a beta of 0.40. The firm has a fifty day moving average price of $91.15 and a 200 day moving average price of $92.48.
Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the previous year, the company posted $0.87 EPS. Sell-side analysts predict that Colgate-Palmolive will post 3.75 EPS for the current year.
Colgate-Palmolive Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Thursday, April 17th will be paid a $0.52 dividend. The ex-dividend date is Thursday, April 17th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.50. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.18%. Colgate-Palmolive’s payout ratio is 59.09%.
Colgate-Palmolive announced that its Board of Directors has approved a stock buyback plan on Thursday, March 20th that authorizes the company to repurchase $5.00 billion in shares. This repurchase authorization authorizes the company to reacquire up to 6.8% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s leadership believes its shares are undervalued.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Tariff Exemptions Set the Stage for a Taiwan Semiconductor Rally
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Mitigating Tariffs: 3 Stocks to Gain From a Weaker U.S. Dollar
- How to Choose Top Rated Stocks
- Broadcom’s Apple Relationship: AI Opportunity Meets Tariff Risk
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.